Aomics GmbH

Technologies Development and Expertise

We have been innovating the immuno-oncology sector with our following listed key discoveries by using the state-of-the-art technologies

Compounds in Pipeline

Program

Monoclonal antibody

Monoclonal antibody

Small molecule

Small molecule

Discovery/Research

Preclinical

Clinical PoC Trials

Clinical Trial
Phase-I

Clinical Trial
Phase-II

Clinical Trial
Phase-III

NDA Filed
(FDA filing)

AOM-201901
AOM-202001
AOM-Rare-202101
AOM-Covid19-202002

Technologies under development

Phase-1

Conceptualization

Phase-2

Proof of Concept

Phase-3

Testing & Validation

Phase-4

Launch & Marketing

Phase-5

Scaling & Establishing

Onco-Cure
Immuno-Oncology data analysis pipeline
MULTIOMICS-ImmunoAI
Multi-omics based AI pipeline

Technologies/tools we utilise

AI/ML Development

Application Development

Blockchain Development

Blockchain_Technology

Would you like to start a project with us?

Reach out on the given number or write us an email for further queries regarding project requirements